Moreover, SMURF1 overexpression in ccRCC cells not only resulted in growth and metastasis, but also increased the activation of the ERK/RSK1 and PI3K/AKT/mTOR pathways via DAB2IP inhibition. This evidence concerns the gene SMURF1 and nonpapillary renal cell carcinoma.